Our dedication to improving patient lives drives our mission to license, develop, and commercialize novel therapies. We identify high-potential opportunities and build on current pathways with a vision to reshape the treatment landscape.

Our product development approaches

We focus on advancing early-stage FIC and BIC technologies in the TPD field through the following approaches:
1. Technology Scouting and Data Validation
    Identify breakthrough TPD innovations from leading Asia-Pacific laboratories and biotech companies.
2. Conduct rigorous validation, standardization, and proof-of-concept (POC) studies to solidify scientific value.
3. Regulatory Compliance and US Market Readiness
    - Align technologies with US regulatory requirements, including FDA compliance;
    - Creating tailored market strategies to differentiate these innovations and support their entry into global markets.

Collaboration Services

1. Data Standardization and Technology Localization
    - Aligning data formats and regulatory documentation with US standards;
    - Delivering FDA-compliant preclinical data packages to support IND filings.
2. FIC Technology Identification and Validation
    - Identifying early-stage FIC TPD technologies with high potential;
    - Conducting small-scale proof-of-concept (POC) studies to validate feasibility.
3. Market Potential Analysis
    - Evaluating the application of technologies in high-value therapeutic areas, particularly in oncology and autoimmune indications.
4. Providing competitive landscape analysis for optimal market positioning
5. Cross-Border Project Management and Collaboration
    - Enabling efficient communication and collaboration between Asia-Pacific laboratories and US biotech;
    - Supporting end-to-end project management to ensure alignment and timely delivery.